Diabetes

A 5-year study reveals that the properly constructed diet, along with exercise aimed at muscle maintenance, can achieve long-term weight loss results.

Patients whose blood sugar and insulin delivery was managed by software had been control than those who had to self-monitor their insulin delivery.

The path to President Obama's Precision Medicine Initiative has been paved as is evident from a report released by a Working Group convened by the National Institutes of Health.

Work at the Karolinska Institutet has revealed a potential new therapeutic target in type 2 diabetes.

The long-term claimed to be the first to use real world data to capture the complete picture of the value of paying for bariatric surgery in patients with diabetes.

Presentation of results at the European Association for the Study of Diabetes follows the announcement of topline results in August. For years, researchers and pharmaceutical leaders alike wondered if a diabetes therapy would be shown to have a cardioprotective effect.

Evidence-Based Diabetes Management gained exclusive access to the Comprehensive Weight Management Program for a view of what "behavioral change" really means for patients overcoming obesity and for the clinicians managing their care.

The company's Prevent program is approved by CDC as meeting standards for obesity prevention counseling as required of payers by the US Prevention Services Task Force.

Many more patient than provider characteristics are associated with optimal or poor glycemic control and treatment intensification when glycemic control is initially lost.

Researchers analyzed patient records from a 25-year period and found risks increased with higher doses and longer periods of treatment.

Regulatory filings with the FDA are expected before the end of the year.

People with insurance have significantly higher probabilities of being diagnosed for diabetes, hypercholesterolemia, and hypertension than people without insurance.

Peter Weiden, MD, says that psychiatrists have greater ability to address side effects from antipsychotics than they did 10 years ago. It's essential that clinicians take patient concerns seriously, because when they don't patients may react by stopping their medication.

As CMS pushes healthcare systems to move away from fee-for-service, the state's largest insurer makes a major move toward value-based payment.

Research shows that about 150 minutes per week of moderate exercise, such as walking, can have significant health benefits. Changes in American lifestyles in recent decades have made limited the amount of time spent walking, with unfortunate results.

Exercise is still recommended for those who are overweight, but the study suggests a vitamin C supplement can help those patients who can't or won't pursue activity.

FDA has warned that the drug class dipeptidyl peptidase-4 (DPP-4) inhibitors may cause joint pain that can be severe and disabling. In a statement, the FDA said said it had issued a "warning and precaution" to all labels in this drug class.

The experiments are revealing the relationship between bacteria in the digestive tract and a genetic disposition toward diabetes or obesity.

The difference between "heart age" and chronological age indicates risk of events like heart attacks and strokes, and could motivate younger patients to improve unhealthy lifestyles.

NYU researchers find most meals aimed at kids wouldn't meet restrictions on calories, fat, and salt.

While it's exciting to see more and more physicians wanting to participate in clinical, they need a little background, support, and infrastructure to do so, said Robert Gabbay, MD, PhD, chief medical officer and senior vice president of Joslin Diabetes Center.

Approval for the technology, which integrates with a smartphone, came sooner than company officials expected.

The new guidance released by HRSA proposes to improve oversight over the drug pricing program.

The latest option combines empagliflozin and metformin hydrochloride.

Both ExpressScripts and CVS Health say the new class of cholesterol-fighting drugs will be generally unavailable until their P&T committees complete evaluations, and negotiations for discounts or exclusive deals occur.